DOI: 10.2337/db06-1355
Global Assessment of Regulation of Phosphorylation of Insulin Receptor Substrate (IRS)-1 by Insulin in Vivo in Human Muscle
1Center for Metabolic Biology, Arizona State University, Tempe, Arizona Correspondence: lawrence.mandarino{at}asu.edu Objective.: Research has focused on Insulin Receptor Substrate-1 (IRS-1) as a locus for insulin resistance. Tyrosine phosphorylation of IRS-1 initiates insulin signaling; serine/threonine phosphorylation alters the ability of IRS-1 to transduce the insulin signal. Of 1242 amino acids in IRS-1, 242 are serine/threonine. Serine/threonine phosphorylation of IRS-1 is affected by many factors, including insulin. The purpose of this study was to perform global assessment of phosphorylation of serine/threonine residues in IRS-1 in vivo in humans. Research Design and Methods.: In this report we describe our use of capillary HPLC-electrospray tandem mass spectrometry to identify/quantify site-specific phosphorylation of IRS-1 in human vastus lateralis muscle obtained by needle biopsy, basally and after insulin infusion in four healthy volunteers. Results.: Twenty-two serine/threonine phosphorylation sites were identified; fifteen were quantified. Three sites had not been identified previously (Thr495, Ser527, and S1005). Insulin increased the phosphorylation of Ser312, Ser616, Ser636, Ser892, Ser1101, and Ser1223 (2.6 ± 0.4, 2.9 ± 0.8, 2.1 ± 0.3, 1.6 ± 0.1, 1.3 ± 0.1, and 1.3 ± 0.1 fold, respectively, compared to basal; P < 0.05); phosphorylation of Ser348, Thr446, Thr495, and Ser1005 decreased (0.4 ± 0.1, 0.2 ± 0.1, 0.1 ± 0.1, and 0.3 ± 0.2 fold, respectively; P < 0.05). Conclusions.: These results provide an assessment of IRS-1 phosphorylation in vivo and show that insulin has profound effects on IRS-1 serine/threonine phosphorylation in healthy humans.
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||